Total Payments
$2,728
2024 Payments
$854.76
Companies
16
Transactions
153
Payment Breakdown by Category
Food & Beverage$2,609 (95.7%)
Other$118.36 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,609 | 152 | 95.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $118.36 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $930.02 | 47 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $477.86 | 46 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $270.02 | 13 | $0 (2024) |
| Alkermes, Inc. | $246.33 | 15 | $0 (2024) |
| AbbVie Inc. | $141.89 | 5 | $0 (2023) |
| Indivior Inc. | $133.82 | 2 | $0 (2020) |
| ITI, Inc. | $131.75 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2019) |
| Lundbeck LLC | $70.10 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $57.31 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $854.76 | 56 | Teva Pharmaceuticals USA, Inc. ($290.72) |
| 2023 | $757.72 | 43 | Neurocrine Biosciences, Inc. ($378.30) |
| 2022 | $323.10 | 23 | Neurocrine Biosciences, Inc. ($139.32) |
| 2021 | $259.30 | 18 | Otsuka America Pharmaceutical, Inc. ($63.76) |
| 2020 | $64.07 | 4 | Sunovion Pharmaceuticals Inc. ($18.54) |
| 2019 | $290.21 | 4 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2018 | $26.82 | 2 | Alkermes, Inc. ($26.82) |
| 2017 | $151.66 | 3 | Indivior Inc. ($118.36) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CNS | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CNS | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.77 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Neuropsychiatry | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Central Nervous System | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Central Nervous System | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Neuropsychiatry | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Neurology | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Neurology | ||||||
About Dr. Phyllis Bryant-Mobley, M.D
Dr. Phyllis Bryant-Mobley, M.D is a Psychiatry healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902891294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phyllis Bryant-Mobley, M.D has received a total of $2,728 in payments from pharmaceutical and medical device companies, with $854.76 received in 2024. These payments were reported across 153 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,609).
Ad
Practice Information
- Specialty Psychiatry
- Location Columbia, SC
- Active Since 09/13/2005
- Last Updated 07/16/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1902891294
Products in Payments
- INGREZZA (Drug) $930.02
- REXULTI (Drug) $259.29
- Austedo XR (Drug) $242.37
- ARISTADA (Drug) $219.51
- UZEDY (Drug) $145.54
- VRAYLAR (Drug) $141.89
- CAPLYTA (Drug) $131.75
- FARXIGA (Drug) $125.00
- SUBOXONE SUBLINGUAL FILM (Drug) $118.36
- AUSTEDO (Drug) $89.95
- ABILIFY MAINTENA (Drug) $60.84
- INVEGA SUSTENNA (Drug) $45.13
- LATUDA (Drug) $33.38
- Aristada 441 mg (Drug) $26.82
- ABILIFY ASIMTUFII (Drug) $19.99
- COBENFY (Drug) $19.99
- HETLIOZ (Drug) $17.84
- SECUADO (Drug) $15.57
- PERSERIS (Drug) $15.46
- APTIMA (Device) $12.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbia
Dr. Meera Narasimhan, M.d, M.D
Psychiatry — Payments: $57,045
Psychiatry $57,045
Dr. Joseph Parks, M.d, M.D
Psychiatry — Payments: $53,504
Psychiatry $53,504
Agara Reddy, Md, MD
Psychiatry — Payments: $15,068
Psychiatry $15,068
Deborah Leverette, Md Mph, MD MPH
Psychiatry — Payments: $12,750
Psychiatry $12,750
Gariane Gunter, M.d, M.D
Psychiatry — Payments: $11,480
Psychiatry $11,480
Dr. Nioaka Campbell, M.d, M.D
Psychiatry — Payments: $10,898
Psychiatry $10,898